Medtronic plc MDT recently announced late-breaking data from the global Lead Evaluation for Defibrillation and Reliability (“LEADR”) Pivotal trial at Heart Rhythm 2024. The outcome showed that the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results